

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.14081055 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.14081055 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.83818576 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.83818576 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.45583565 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.44295741 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.24509646 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.13980164 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.82537998 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.82537998 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.82537998 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.67450686 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.62208438 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.59291233 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.57210571 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.49850884 |
| 17 | urea cycle (GO:0000050) | 5.49050363 |
| 18 | urea metabolic process (GO:0019627) | 5.49050363 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.41810984 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41450393 |
| 21 | protein carboxylation (GO:0018214) | 5.32558199 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32558199 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.31685000 |
| 24 | * complement activation, alternative pathway (GO:0006957) | 5.28638614 |
| 25 | cysteine metabolic process (GO:0006534) | 5.27458679 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.25639687 |
| 27 | * regulation of protein activation cascade (GO:2000257) | 5.24392750 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.18666948 |
| 29 | regulation of apoptotic cell clearance (GO:2000425) | 5.11108860 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.03719902 |
| 31 | negative regulation of protein activation cascade (GO:2000258) | 4.99400911 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.90867141 |
| 33 | * regulation of complement activation (GO:0030449) | 4.89029590 |
| 34 | bile acid metabolic process (GO:0008206) | 4.83951302 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82112042 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.77301182 |
| 37 | regulation of plasminogen activation (GO:0010755) | 4.76435577 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.74784467 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.73826073 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.68302679 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.66318465 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.66318465 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.66192190 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.62567872 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.62567872 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.62567872 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.55682611 |
| 48 | * regulation of humoral immune response (GO:0002920) | 4.55416058 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.53466145 |
| 50 | lysine catabolic process (GO:0006554) | 4.52525846 |
| 51 | lysine metabolic process (GO:0006553) | 4.52525846 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.51109669 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.51109669 |
| 54 | phospholipid efflux (GO:0033700) | 4.49242714 |
| 55 | drug metabolic process (GO:0017144) | 4.46884201 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.46709635 |
| 57 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.45928467 |
| 58 | intestinal cholesterol absorption (GO:0030299) | 4.43522865 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.41831679 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.38634068 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.38634068 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.36424532 |
| 63 | ethanol metabolic process (GO:0006067) | 4.34371204 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.29576984 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.23338412 |
| 66 | negative regulation of complement activation (GO:0045916) | 4.22352758 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.21106993 |
| 68 | cellular glucuronidation (GO:0052695) | 4.14835621 |
| 69 | cholesterol efflux (GO:0033344) | 4.11773936 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.11392188 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.07573271 |
| 72 | glutamate metabolic process (GO:0006536) | 4.06820303 |
| 73 | glycine metabolic process (GO:0006544) | 4.02556853 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.02383841 |
| 75 | positive regulation of blood coagulation (GO:0030194) | 4.00549366 |
| 76 | positive regulation of hemostasis (GO:1900048) | 4.00549366 |
| 77 | amine catabolic process (GO:0009310) | 4.00532738 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 4.00532738 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 4.00388029 |
| 80 | coenzyme catabolic process (GO:0009109) | 4.00116857 |
| 81 | fibrinolysis (GO:0042730) | 3.97426313 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.97225301 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.94985936 |
| 84 | drug catabolic process (GO:0042737) | 3.94309676 |
| 85 | ethanol oxidation (GO:0006069) | 3.94283202 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.91821570 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.90076640 |
| 88 | arginine metabolic process (GO:0006525) | 3.89655835 |
| 89 | acute inflammatory response (GO:0002526) | 3.87864254 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85663498 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79769841 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.79121724 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76136146 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76136146 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.75847204 |
| 96 | positive regulation of coagulation (GO:0050820) | 3.75373083 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.72609084 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.72609084 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.71897068 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.71422476 |
| 101 | ketone body metabolic process (GO:1902224) | 3.70696928 |
| 102 | protein-lipid complex subunit organization (GO:0071825) | 3.70561726 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.69914030 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69321213 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.67483441 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.65832146 |
| 107 | oxidative demethylation (GO:0070989) | 3.64718846 |
| 108 | sterol homeostasis (GO:0055092) | 3.64689931 |
| 109 | * protein activation cascade (GO:0072376) | 3.63575114 |
| 110 | cofactor catabolic process (GO:0051187) | 3.63087570 |
| 111 | * complement activation (GO:0006956) | 3.62704481 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.60631528 |
| 113 | organic acid catabolic process (GO:0016054) | 3.60631528 |
| 114 | acute-phase response (GO:0006953) | 3.59676299 |
| 115 | negative regulation of lipase activity (GO:0060192) | 3.59417276 |
| 116 | phenylpropanoid metabolic process (GO:0009698) | 3.58943085 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.57276067 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.54334105 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.53797336 |
| 120 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53722059 |
| 121 | opsonization (GO:0008228) | 3.51793137 |
| 122 | protein-lipid complex assembly (GO:0065005) | 3.51266740 |
| 123 | urate metabolic process (GO:0046415) | 3.50469690 |
| 124 | cytolysis (GO:0019835) | 3.47789647 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.47546575 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.47069243 |
| 127 | intestinal absorption (GO:0050892) | 3.46112233 |
| 128 | hormone catabolic process (GO:0042447) | 3.43201437 |
| 129 | negative regulation of humoral immune response (GO:0002921) | 3.42410651 |
| 130 | * regulation of acute inflammatory response (GO:0002673) | 3.26946040 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.18007151 |
| 132 | alkaloid metabolic process (GO:0009820) | 3.14618171 |
| 133 | primary alcohol catabolic process (GO:0034310) | 3.12205777 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.11623253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.95949570 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.83685493 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54131361 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21942390 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.19041716 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95718234 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.79414979 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.84724750 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.69179864 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34299914 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05506436 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2938239 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94822649 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94230626 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77585951 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75511236 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73722375 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66760987 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56578541 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53361903 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53267381 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47753409 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35649602 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30804710 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29965230 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22276630 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20415174 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13575362 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11877893 |
| 30 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11522753 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10082692 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07225516 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03786515 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03402966 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98024509 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96531230 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96399762 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96319267 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95072385 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91359961 |
| 41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91155576 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90651953 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90272814 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90094013 |
| 45 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89553027 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89002879 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85369978 |
| 48 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85254131 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85239777 |
| 50 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83578898 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80501947 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79153345 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78513607 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78019826 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75179013 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75163654 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74948445 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74948445 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.74864558 |
| 60 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74304110 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73600990 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73321931 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71677043 |
| 64 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71454840 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70948093 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70907476 |
| 67 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69470666 |
| 68 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69084722 |
| 69 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68286508 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68230994 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67825479 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67569714 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.67481873 |
| 74 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67139054 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67087428 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.66336229 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65846404 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.64614755 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.64253344 |
| 80 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.64054367 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.62415424 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.62415424 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.62126629 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61874953 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60601799 |
| 86 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.59780863 |
| 87 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.59628651 |
| 88 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59344446 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58981660 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.58928983 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.58261685 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.58124720 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.57525475 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57473264 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55985680 |
| 96 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55338020 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54037385 |
| 98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53739541 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.53437633 |
| 100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53413172 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53076827 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52358305 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51769271 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51638765 |
| 105 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.51549877 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.50643390 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50542356 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.49494723 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48834990 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48388272 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.48163104 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46729657 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43836239 |
| 114 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43785368 |
| 115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43622705 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.43094105 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43066209 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42454484 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.41734605 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41348538 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.41250439 |
| 122 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40654913 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.40620659 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40575619 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.40431479 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.40271430 |
| 127 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.39549713 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39452014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.88984592 |
| 2 | MP0005360_urolithiasis | 7.35828326 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.07002122 |
| 4 | MP0005365_abnormal_bile_salt | 5.78333064 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.80668997 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.90723560 |
| 7 | MP0003252_abnormal_bile_duct | 3.89164383 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.47795888 |
| 9 | MP0009840_abnormal_foam_cell | 3.30480891 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03589828 |
| 11 | MP0003195_calcinosis | 2.79829130 |
| 12 | MP0005332_abnormal_amino_acid | 2.74483496 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.63373378 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.51692389 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.26811907 |
| 16 | MP0000609_abnormal_liver_physiology | 2.16046629 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.14238955 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.08937463 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.05757835 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.85385935 |
| 21 | MP0001764_abnormal_homeostasis | 1.69504890 |
| 22 | MP0003868_abnormal_feces_composition | 1.65471606 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57382567 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.40160923 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.38697569 |
| 26 | MP0005451_abnormal_body_composition | 1.37910476 |
| 27 | MP0003186_abnormal_redox_activity | 1.37863095 |
| 28 | MP0009697_abnormal_copulation | 1.31996941 |
| 29 | MP0003011_delayed_dark_adaptation | 1.31884597 |
| 30 | MP0000604_amyloidosis | 1.24895256 |
| 31 | MP0002254_reproductive_system_inflammat | 1.24581484 |
| 32 | MP0009764_decreased_sensitivity_to | 1.22069108 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.21094817 |
| 34 | MP0002132_abnormal_respiratory_system | 1.19393434 |
| 35 | MP0000598_abnormal_liver_morphology | 1.18534414 |
| 36 | MP0005023_abnormal_wound_healing | 1.15786447 |
| 37 | MP0003303_peritoneal_inflammation | 1.15763135 |
| 38 | MP0009763_increased_sensitivity_to | 1.08932401 |
| 39 | * MP0008469_abnormal_protein_level | 1.05334935 |
| 40 | MP0005647_abnormal_sex_gland | 1.04295747 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.02603936 |
| 42 | MP0010368_abnormal_lymphatic_system | 0.97805371 |
| 43 | MP0010155_abnormal_intestine_physiology | 0.96776884 |
| 44 | MP0005670_abnormal_white_adipose | 0.92825490 |
| 45 | MP0003724_increased_susceptibility_to | 0.92451627 |
| 46 | MP0001915_intracranial_hemorrhage | 0.89120892 |
| 47 | * MP0009642_abnormal_blood_homeostasis | 0.88475844 |
| 48 | MP0003183_abnormal_peptide_metabolism | 0.85242431 |
| 49 | MP0002909_abnormal_adrenal_gland | 0.82492409 |
| 50 | MP0005376_homeostasis/metabolism_phenot | 0.80001649 |
| 51 | MP0005409_darkened_coat_color | 0.79905351 |
| 52 | MP0002971_abnormal_brown_adipose | 0.78577561 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 0.78412002 |
| 54 | MP0003690_abnormal_glial_cell | 0.78077596 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.77268988 |
| 56 | MP0004130_abnormal_muscle_cell | 0.76155087 |
| 57 | MP0003879_abnormal_hair_cell | 0.74882894 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 0.74751022 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.74749315 |
| 60 | MP0004272_abnormal_basement_membrane | 0.74690376 |
| 61 | MP0001756_abnormal_urination | 0.74598782 |
| 62 | MP0005408_hypopigmentation | 0.74417244 |
| 63 | MP0005334_abnormal_fat_pad | 0.70423901 |
| 64 | MP0005464_abnormal_platelet_physiology | 0.70414897 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.70394972 |
| 66 | MP0001661_extended_life_span | 0.69683160 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 0.69520594 |
| 68 | MP0005535_abnormal_body_temperature | 0.69047710 |
| 69 | MP0003329_amyloid_beta_deposits | 0.67362367 |
| 70 | MP0003075_altered_response_to | 0.66850294 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.65482630 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.65045950 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.64564565 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.64059605 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.63541827 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.62818254 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.62590189 |
| 78 | MP0000858_altered_metastatic_potential | 0.61099574 |
| 79 | MP0009053_abnormal_anal_canal | 0.59897462 |
| 80 | MP0006054_spinal_hemorrhage | 0.59852320 |
| 81 | * MP0003436_decreased_susceptibility_to | 0.59245357 |
| 82 | MP0009785_altered_susceptibility_to | 0.59188064 |
| 83 | MP0005166_decreased_susceptibility_to | 0.58470096 |
| 84 | MP0006082_CNS_inflammation | 0.58352015 |
| 85 | MP0002928_abnormal_bile_duct | 0.58234608 |
| 86 | MP0000566_synostosis | 0.56868499 |
| 87 | MP0005395_other_phenotype | 0.56738626 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.55864301 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.55405342 |
| 90 | MP0005448_abnormal_energy_balance | 0.55287542 |
| 91 | MP0008004_abnormal_stomach_pH | 0.54443741 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.54378303 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.54174048 |
| 94 | MP0005266_abnormal_metabolism | 0.53793347 |
| 95 | MP0005387_immune_system_phenotype | 0.51709743 |
| 96 | MP0001790_abnormal_immune_system | 0.51709743 |
| 97 | MP0000685_abnormal_immune_system | 0.50960730 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.50468128 |
| 99 | MP0002796_impaired_skin_barrier | 0.50368508 |
| 100 | MP0002933_joint_inflammation | 0.49522173 |
| 101 | * MP0001533_abnormal_skeleton_physiology | 0.48850858 |
| 102 | MP0005165_increased_susceptibility_to | 0.48757328 |
| 103 | MP0002282_abnormal_trachea_morphology | 0.47971048 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.47722551 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.46646363 |
| 106 | MP0002168_other_aberrant_phenotype | 0.46378100 |
| 107 | MP0008873_increased_physiological_sensi | 0.46231016 |
| 108 | MP0000249_abnormal_blood_vessel | 0.45974149 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.45382422 |
| 110 | MP0004883_abnormal_blood_vessel | 0.45347027 |
| 111 | MP0005164_abnormal_response_to | 0.44797039 |
| 112 | MP0001881_abnormal_mammary_gland | 0.44472592 |
| 113 | MP0003718_maternal_effect | 0.43487503 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.43432013 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.43145004 |
| 116 | MP0004947_skin_inflammation | 0.41519771 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.40405975 |
| 118 | * MP0005025_abnormal_response_to | 0.40296869 |
| 119 | MP0009115_abnormal_fat_cell | 0.40168950 |
| 120 | MP0001853_heart_inflammation | 0.39681790 |
| 121 | MP0001243_abnormal_dermal_layer | 0.39562356 |
| 122 | MP0008874_decreased_physiological_sensi | 0.39124640 |
| 123 | MP0003953_abnormal_hormone_level | 0.37546904 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.36664055 |
| 125 | * MP0002419_abnormal_innate_immunity | 0.36595168 |
| 126 | MP0002060_abnormal_skin_morphology | 0.33471677 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.32800156 |
| 128 | MP0002970_abnormal_white_adipose | 0.31511063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.20938884 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.87270010 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.87023771 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.31757904 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.28551033 |
| 6 | Xanthomatosis (HP:0000991) | 6.15127774 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.97165742 |
| 8 | Complement deficiency (HP:0004431) | 5.55050523 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.21187632 |
| 10 | Joint hemorrhage (HP:0005261) | 4.87229023 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.57497104 |
| 12 | Hyperammonemia (HP:0001987) | 4.45854624 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44660171 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.44386301 |
| 15 | Epidermoid cyst (HP:0200040) | 4.37957348 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20268301 |
| 17 | Hyperglycinemia (HP:0002154) | 4.16828112 |
| 18 | Abnormality of complement system (HP:0005339) | 4.13846836 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.08986952 |
| 20 | Ketosis (HP:0001946) | 4.08963982 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.07973980 |
| 22 | Hyperglycinuria (HP:0003108) | 4.04278051 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.94685517 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.93673686 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.93673686 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.91216272 |
| 27 | Fat malabsorption (HP:0002630) | 3.90278250 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.74572616 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56894613 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54983696 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.51408815 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.46877834 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.37211551 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29788309 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18972127 |
| 36 | Myocardial infarction (HP:0001658) | 3.13713296 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13533258 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.11571988 |
| 39 | Purpura (HP:0000979) | 3.06348859 |
| 40 | Spontaneous abortion (HP:0005268) | 3.00899160 |
| 41 | Ketoacidosis (HP:0001993) | 2.94588671 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.93804809 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.91852581 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89257962 |
| 45 | Steatorrhea (HP:0002570) | 2.88450243 |
| 46 | Glomerulonephritis (HP:0000099) | 2.87406721 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.84874408 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.83082859 |
| 49 | Skin nodule (HP:0200036) | 2.73902684 |
| 50 | Gout (HP:0001997) | 2.72479778 |
| 51 | Vascular calcification (HP:0004934) | 2.71552225 |
| 52 | Metabolic acidosis (HP:0001942) | 2.67005550 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.60839499 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60839499 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.60716662 |
| 56 | Lethargy (HP:0001254) | 2.48938319 |
| 57 | Spastic diplegia (HP:0001264) | 2.48012999 |
| 58 | Acanthocytosis (HP:0001927) | 2.46147021 |
| 59 | Esophageal varix (HP:0002040) | 2.44900161 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.44012177 |
| 61 | Amyloidosis (HP:0011034) | 2.43760714 |
| 62 | Mitral stenosis (HP:0001718) | 2.41973629 |
| 63 | Gingival bleeding (HP:0000225) | 2.40142274 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.36801045 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.36801045 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.34888948 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.33662064 |
| 68 | Neonatal onset (HP:0003623) | 2.32685696 |
| 69 | Irritability (HP:0000737) | 2.29228841 |
| 70 | Cholelithiasis (HP:0001081) | 2.29044570 |
| 71 | Malnutrition (HP:0004395) | 2.26393749 |
| 72 | Menorrhagia (HP:0000132) | 2.25103149 |
| 73 | Cholecystitis (HP:0001082) | 2.22561818 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.22561818 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.20941189 |
| 76 | Pancreatitis (HP:0001733) | 2.20837427 |
| 77 | Osteomalacia (HP:0002749) | 2.19273035 |
| 78 | Cerebral edema (HP:0002181) | 2.17178516 |
| 79 | Increased serum ferritin (HP:0003281) | 2.16188817 |
| 80 | Thrombophlebitis (HP:0004418) | 2.15851731 |
| 81 | Hyperphosphatemia (HP:0002905) | 2.14566561 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.13887498 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.13745764 |
| 84 | Joint swelling (HP:0001386) | 2.11765684 |
| 85 | Pulmonary embolism (HP:0002204) | 2.11560952 |
| 86 | Nephritis (HP:0000123) | 2.10280635 |
| 87 | Late onset (HP:0003584) | 2.06463612 |
| 88 | Vomiting (HP:0002013) | 2.04522617 |
| 89 | Alkalosis (HP:0001948) | 2.01802345 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 2.00875164 |
| 91 | Enlarged kidneys (HP:0000105) | 1.99514585 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 1.99485261 |
| 93 | Mucopolysacchariduria (HP:0008155) | 1.97190997 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97190997 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95991188 |
| 96 | Rickets (HP:0002748) | 1.93228214 |
| 97 | Opisthotonus (HP:0002179) | 1.91185838 |
| 98 | Poikilocytosis (HP:0004447) | 1.91037002 |
| 99 | Hypophosphatemia (HP:0002148) | 1.90821365 |
| 100 | Abnormality of the gallbladder (HP:0005264) | 1.90335051 |
| 101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90149311 |
| 102 | Elevated alkaline phosphatase (HP:0003155) | 1.89393628 |
| 103 | Gangrene (HP:0100758) | 1.88735445 |
| 104 | Hyperuricemia (HP:0002149) | 1.88144379 |
| 105 | Increased purine levels (HP:0004368) | 1.88144379 |
| 106 | Hyperphosphaturia (HP:0003109) | 1.86012493 |
| 107 | Proximal tubulopathy (HP:0000114) | 1.85739101 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.85718748 |
| 109 | Brushfield spots (HP:0001088) | 1.84564496 |
| 110 | Vacuolated lymphocytes (HP:0001922) | 1.83284989 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82548521 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81436376 |
| 113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81436376 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81436376 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80711531 |
| 116 | Hypertriglyceridemia (HP:0002155) | 1.75935562 |
| 117 | Nausea (HP:0002018) | 1.75044377 |
| 118 | Orchitis (HP:0100796) | 1.74825819 |
| 119 | Tetany (HP:0001281) | 1.74542593 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.74516673 |
| 121 | Abnormality of vitamin metabolism (HP:0100508) | 1.74005182 |
| 122 | Arthropathy (HP:0003040) | 1.70944837 |
| 123 | Abnormality of carpal bone ossification (HP:0006257) | 1.70179440 |
| 124 | Widely patent fontanelles and sutures (HP:0004492) | 1.69074549 |
| 125 | Flat acetabular roof (HP:0003180) | 1.69037250 |
| 126 | Epistaxis (HP:0000421) | 1.67719039 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.67676582 |
| 128 | Metaphyseal irregularity (HP:0003025) | 1.63002149 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 1.62416196 |
| 130 | Glomerulosclerosis (HP:0000096) | 1.62087411 |
| 131 | Fair hair (HP:0002286) | 1.60959177 |
| 132 | Focal segmental glomerulosclerosis (HP:0000097) | 1.59284543 |
| 133 | Retrobulbar optic neuritis (HP:0100654) | 1.59143640 |
| 134 | Optic neuritis (HP:0100653) | 1.59143640 |
| 135 | Glycosuria (HP:0003076) | 1.57385973 |
| 136 | Abnormality of urine glucose concentration (HP:0011016) | 1.57385973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.94741380 |
| 2 | FGFR4 | 4.50843930 |
| 3 | ERN1 | 4.45985870 |
| 4 | SIK1 | 3.96031703 |
| 5 | MST1R | 2.87198052 |
| 6 | TAOK3 | 2.70926395 |
| 7 | LMTK2 | 2.65774519 |
| 8 | ERBB4 | 2.42749967 |
| 9 | INSRR | 2.39961748 |
| 10 | TYK2 | 2.32165156 |
| 11 | TRIB3 | 2.18710255 |
| 12 | PKN2 | 2.10196549 |
| 13 | ICK | 1.92589956 |
| 14 | PDGFRA | 1.83311837 |
| 15 | TBK1 | 1.79715870 |
| 16 | STK38L | 1.71883560 |
| 17 | DDR2 | 1.67727376 |
| 18 | MAPK11 | 1.66721640 |
| 19 | MAP2K4 | 1.65713105 |
| 20 | MAP3K7 | 1.59430242 |
| 21 | PTK6 | 1.56344527 |
| 22 | PDK2 | 1.55662284 |
| 23 | PIK3CG | 1.50218742 |
| 24 | FLT3 | 1.48030532 |
| 25 | ABL2 | 1.45222146 |
| 26 | FRK | 1.43788960 |
| 27 | MAP3K14 | 1.42525629 |
| 28 | JAK1 | 1.42057941 |
| 29 | KDR | 1.37728613 |
| 30 | DAPK2 | 1.36246710 |
| 31 | EPHB1 | 1.33308981 |
| 32 | STK24 | 1.31845801 |
| 33 | NEK9 | 1.30572354 |
| 34 | LATS1 | 1.29032595 |
| 35 | MAP3K12 | 1.28021994 |
| 36 | JAK2 | 1.26454177 |
| 37 | NUAK1 | 1.24164611 |
| 38 | CDC42BPA | 1.22014632 |
| 39 | CSK | 1.20656513 |
| 40 | IKBKE | 1.17748972 |
| 41 | RIPK1 | 1.11414805 |
| 42 | MET | 1.07188680 |
| 43 | EPHA3 | 1.05624262 |
| 44 | TGFBR2 | 1.05287714 |
| 45 | PRKAA2 | 1.02676212 |
| 46 | CAMK1D | 1.02217604 |
| 47 | PIK3CA | 1.01566435 |
| 48 | MYLK | 0.99625466 |
| 49 | ERBB2 | 0.99029603 |
| 50 | GRK6 | 0.98675356 |
| 51 | MAPKAPK3 | 0.98594850 |
| 52 | MAP2K3 | 0.96269981 |
| 53 | PRKG2 | 0.94577409 |
| 54 | FGFR2 | 0.92144770 |
| 55 | MAP3K3 | 0.91090630 |
| 56 | NLK | 0.90660705 |
| 57 | PRPF4B | 0.89845345 |
| 58 | IRAK3 | 0.89100001 |
| 59 | TIE1 | 0.88549789 |
| 60 | MATK | 0.85635481 |
| 61 | FGFR3 | 0.85530498 |
| 62 | MAP3K10 | 0.85155653 |
| 63 | EPHA2 | 0.84448910 |
| 64 | MAPK4 | 0.80024321 |
| 65 | EPHB2 | 0.73214123 |
| 66 | PRKCZ | 0.72795453 |
| 67 | LATS2 | 0.70254539 |
| 68 | CDK6 | 0.69332609 |
| 69 | PDPK1 | 0.69230343 |
| 70 | MAP2K2 | 0.67707195 |
| 71 | PBK | 0.67558625 |
| 72 | GSK3A | 0.67372728 |
| 73 | MAP3K11 | 0.66123473 |
| 74 | SMG1 | 0.65348961 |
| 75 | PIM2 | 0.65215535 |
| 76 | PRKACG | 0.64773135 |
| 77 | BLK | 0.64686949 |
| 78 | PDGFRB | 0.62894419 |
| 79 | MAP2K1 | 0.61200216 |
| 80 | PTK2 | 0.60738537 |
| 81 | KIT | 0.60520351 |
| 82 | MAPK15 | 0.60477452 |
| 83 | TAOK2 | 0.60076309 |
| 84 | MAP3K6 | 0.59540390 |
| 85 | CSF1R | 0.57490313 |
| 86 | PINK1 | 0.55129765 |
| 87 | CDK12 | 0.54069997 |
| 88 | MAPK12 | 0.54062220 |
| 89 | BMX | 0.53767356 |
| 90 | MAP3K13 | 0.53559382 |
| 91 | CAMK2G | 0.52498118 |
| 92 | PRKCQ | 0.51797072 |
| 93 | ACVR1B | 0.51249821 |
| 94 | PRKAA1 | 0.49514205 |
| 95 | FGFR1 | 0.49300366 |
| 96 | SGK3 | 0.49124656 |
| 97 | DYRK1B | 0.48891533 |
| 98 | WNK4 | 0.47990607 |
| 99 | AKT3 | 0.47198541 |
| 100 | MAP4K1 | 0.47151636 |
| 101 | HIPK2 | 0.47045764 |
| 102 | CDK4 | 0.46598640 |
| 103 | PAK4 | 0.46281244 |
| 104 | PDK1 | 0.45733322 |
| 105 | SRC | 0.45265300 |
| 106 | IGF1R | 0.43499137 |
| 107 | NEK6 | 0.43428131 |
| 108 | JAK3 | 0.43079834 |
| 109 | EGFR | 0.42937622 |
| 110 | MAP2K6 | 0.42898536 |
| 111 | CAMK1G | 0.42388669 |
| 112 | ZAP70 | 0.40449981 |
| 113 | GRK7 | 0.39188850 |
| 114 | PKN1 | 0.37805690 |
| 115 | GRK1 | 0.36414377 |
| 116 | MAP3K1 | 0.35492939 |
| 117 | IKBKB | 0.35184204 |
| 118 | STK38 | 0.34509063 |
| 119 | FGR | 0.34145330 |
| 120 | RET | 0.33444875 |
| 121 | MAP3K5 | 0.32427736 |
| 122 | TRPM7 | 0.31670307 |
| 123 | TEC | 0.30637191 |
| 124 | CHUK | 0.30463701 |
| 125 | STK39 | 0.29583828 |
| 126 | FER | 0.28506951 |
| 127 | MAPK7 | 0.27375502 |
| 128 | MTOR | 0.27358416 |
| 129 | ABL1 | 0.25715616 |
| 130 | MAP3K2 | 0.25637850 |
| 131 | IRAK1 | 0.25141222 |
| 132 | TESK1 | 0.25095293 |
| 133 | TYRO3 | 0.23413367 |
| 134 | MAPK3 | 0.23244813 |
| 135 | PRKCA | 0.19505888 |
| 136 | SGK2 | 0.19175627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35874412 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63812668 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37828217 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27610515 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04677742 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84412767 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64130960 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57350096 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56020432 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53971880 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43623604 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39237366 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30874764 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17646557 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.08397679 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07620233 |
| 17 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99298750 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94131010 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93408089 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90120052 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88611723 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85489911 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84350211 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83549988 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82442152 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72338671 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67173466 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64353410 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62190908 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59911803 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57609820 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52900541 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.49056059 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48309981 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47659275 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43862814 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42783772 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33653752 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31475307 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31100661 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26472999 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25539406 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20215821 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18699744 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18515228 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17080796 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14938446 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12564240 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98875435 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97425237 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96290686 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96177273 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96016826 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95046821 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93254780 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92509692 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91802419 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88161357 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79891287 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.76653167 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72646904 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70236705 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67646921 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61450158 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59275878 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58460144 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51462522 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49289299 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42358645 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.39822553 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33089333 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30679925 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29594675 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29175764 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29107300 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28956253 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.27712260 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25015668 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21783180 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15483896 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09838219 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08107019 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.04378440 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04110717 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04108993 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03024850 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.02013667 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01166160 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00498915 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1641104 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1628050 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1581521 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1492772 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1448398 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | -0.1280774 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.1214336 |
| 97 | Malaria_Homo sapiens_hsa05144 | -0.1206303 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1156175 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1024546 |
| 100 | Lysosome_Homo sapiens_hsa04142 | -0.1002966 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | -0.0929908 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0863757 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0750027 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.0570890 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0487571 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0469299 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0400469 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0262931 |
| 109 | Asthma_Homo sapiens_hsa05310 | -0.0247200 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0231817 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0074501 |
| 112 | Influenza A_Homo sapiens_hsa05164 | -0.0041432 |
| 113 | Pertussis_Homo sapiens_hsa05133 | -0.0017190 |

